These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10531220)

  • 1. Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity.
    Nakao H; Kiyokawa N; Fujimoto J; Yamasaki S; Takeda T
    Infect Immun; 1999 Nov; 67(11):5717-22. PubMed ID: 10531220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of humanized monoclonal antibody TMA-15 which neutralizes Shiga toxin 2.
    Kimura T; Co MS; Vasquez M; Wei S; Xu H; Tani S; Sakai Y; Kawamura T; Matsumoto Y; Nakao H; Takeda T
    Hybrid Hybridomics; 2002 Jun; 21(3):161-8. PubMed ID: 12165141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide.
    Smith MJ; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Infect Immun; 2006 Dec; 74(12):6992-8. PubMed ID: 17030576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli.
    Meysick KC; Mills M; O'Brien AD
    Infect Immun; 2001 Apr; 69(4):2066-74. PubMed ID: 11254559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
    Padhye VV; Zhao T; Doyle MP
    J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.
    Smith MJ; Melton-Celsa AR; Sinclair JF; Carvalho HM; Robinson CM; O'Brien AD
    Infect Immun; 2009 Jul; 77(7):2730-40. PubMed ID: 19433543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.
    Strockbine NA; Marques LR; Holmes RK; O'Brien AD
    Infect Immun; 1985 Dec; 50(3):695-700. PubMed ID: 3905611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody to shiga toxin 1, which blocks receptor binding and neutralizes cytotoxicity.
    Nakao H; Kataoka C; Kiyokawa N; Fujimoto J; Yamasaki S; Takeda T
    Microbiol Immunol; 2002; 46(11):777-80. PubMed ID: 12516775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
    Perera LP; Marques LR; O'Brien AD
    J Clin Microbiol; 1988 Oct; 26(10):2127-31. PubMed ID: 3053764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2.
    Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T
    Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
    He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
    J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic necrotizing factor type 1-neutralizing monoclonal antibody NG8 recognizes three amino acids in a C-terminal region of the toxin and reduces toxin binding to HEp-2 cells.
    Grande KK; Meysick KC; Rasmussen SB; O'Brien AD
    Infect Immun; 2009 Jan; 77(1):170-9. PubMed ID: 18955470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.
    Kita E; Yunou Y; Kurioka T; Harada H; Yoshikawa S; Mikasa K; Higashi N
    Infect Immun; 2000 Mar; 68(3):1207-14. PubMed ID: 10678928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and application of a neutralizing linear epitope on liable toxin B of enterotoxin Escherichia coli.
    Guan W; Liu W; Bao J; Li J; Yuan C; Tang J; Shi D
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):5985-96. PubMed ID: 25794873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.
    Strockbine NA; Marques LR; Newland JW; Smith HW; Holmes RK; O'Brien AD
    Infect Immun; 1986 Jul; 53(1):135-40. PubMed ID: 3522426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15.
    Kimura T; Tani S; Motoki M; Matsumoto Y
    Biochem Biophys Res Commun; 2003 Jun; 305(4):1057-60. PubMed ID: 12767937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.